Results per Page:
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
Inching closer to an EBV vaccine?
From the McGuire lab, Vaccine and Infectious Diseases Division
COVID-19 prior to cellular therapy is likely not a cause for alarm.
From the Hill Group, Clinical Research Division and Vaccine and Infectious Disease Division
HIV prevention: does 1+1 = 2?
From HIV Vaccine Trials Network and the HIV Prevention Trials Network, Vaccine and Infectious Disease Division
In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia
From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
When the amount of NS1 matters!
From the Blanco-Melo lab, Vaccine and Infectious Disease Division
Obstáculos relacionados con la interseccionalidad para la atención médica del VIH y las ITS en las comunidades transgénero y no binaria del estado de Washington
Del Comité Asesor de Salud Sexual Trans y No Binaria de Seattle (STARS por sus siglas en inglés) y del Grupo Duerr de Resultados, Prevención y Epidemiología del VIH (HOPE por sus siglas en inglés)
Pertussis vaccination coverage and incidence in King County, Washington
From the Halloran Group, Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Disease Division
Respiratory syncytial virus infection among people experiencing homelessness
From Dr. Denise McCulloch, Vaccine and Infectious Disease Division, Fred Hutch and Division of Allergy and Infectious Diseases, UW, and colleagues
Liver-humanized mice to study hepatis B virus infection
From the Jerome lab, Vaccine and Infectious Disease Division
Bystander-activation of CD8 T cells during Herpes Virus 2 infection
From the Lund lab, Vaccine and Infection Disease Division
Cross-neutralizing Monoclonal Antibodies Against Respiratory Viruses
From the Boonyaratanakornkit, Taylor and Pancera labs, Vaccine and Infectious Disease Division and Cancer Immunology Program, Cancer Consortium
Modeling of human cytomegalovirus infection dynamics in patients
From the Schiffer lab, Vaccine and Infectious Disease Division
Non-traditional signaling: Memory T cells activate innate immunity
From the Zhu and Corey Lab, Vaccine and Infectious Disease Division
Tip Sheet: New findings on immune response to COVID-19, new research from San Antonio Breast Cancer Symposium — and Fred Hutch expert predictions for 2022
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Fred Hutch experts and omicron, closing gaps in indigenous health disparities, new leaders in DEI and data science — and ASH 2021
Summaries of recent Fred Hutch research findings and other news
Fred Hutch at ASH: Latest findings in CAR T-cell therapy, microbiome effects on transplantation, post-transplant COVID-19 — and single-cell genomics for residual disease
The 63rd American Society of Hematology Annual Meeting and Exposition will take place virtually and in person Dec. 11–14 in Atlanta, Georgia
Tip Sheet: How to diversify vaccine clinical trials, 30 years of science education, Trevor Noah talks to Hutch scientists — and more
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: New MacArthur ‘genius,’ returning to school during COVID-19 and the science of race and racism
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Summaries of recent Fred Hutch research findings and other news